All Updates

All Updates

icon
Filter
Funding
Atropos Health raises USD 33 million in Series B funding to amplify stake in value-based care
Telehealth
May 23, 2024
Last week:
Partnerships
Geographic expansion
Lemonade partners with Homesite to expand home insurance services
InsurTech: Personal Lines
Jun 14, 2024
Funding
BayaniPay raises USD 3 million in seed funding to expand payment solutions
Neobanks
Jun 14, 2024
Partnerships
Carbonfuture and Swiss Re partner for long-term carbon removal through biochar
Carbon Management Software
Jun 13, 2024
Funding
Sidekick raises GBP 8.5 million in seed and debt funding to support expansion
Retail Trading Infrastructure
Jun 13, 2024
Partnerships
Climatiq and Epicor partner to reduce CO2 emissions in supply chains
Carbon Management Software
Jun 13, 2024
Product updates
EHang's pilotless eVTOL aircraft concludes first flight launch in Saudi Arabia
Passenger eVTOL Aircraft
Jun 13, 2024
Partnerships
Skyports partners with Unified Aviation to accelerate global network release
Passenger eVTOL Aircraft
Jun 13, 2024
Partnerships
Industry news
USSF chooses Blue Origin, SpaceX, and ULA for ~USD 5.6 billion Pentagon launch contracts
Space Travel and Exploration Tech
Jun 13, 2024
Funding
AnyCreek raises USD 1.8 million in seed funding to enhance platform and expand into new markets
Travel Tech
Jun 13, 2024
Funding
Zeta Labs raises USD 2.9 million in pre-seed funding to develop autonomous AI agent
Generative AI Applications
Jun 13, 2024
May 23, 2024

Atropos Health raises USD 33 million in Series B funding to amplify stake in value-based care

Funding

  • Atropos Health, a health tech company focusing on personalized real-world evidence for care, has secured USD 33 million in Series B funding. The round was led by Valtruis, and contributions from other venture capital firms brought the total funds raised by the company to USD 47 million.

  • The company intends to use the raised funds to amplify its stake in value-based care. Specifically, it plans to fuel its work in GenAI capabilities, scaling the automation of generating personalized real-world data. Additionally, the company plans to secure partnerships with pharmaceutical and vertically integrated healthcare companies to drive evidence adoption in oncology and other specialty areas.

  • Post funding Mike Spadafore, a value-based care veteran, joined Atropos’ board of directors.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.